Insulin glargine and lixisenatide Subcutaneous and Salvax Duo
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Salvax Duo and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: salicylic acid / urea topical
Brand name: Carb-O-Sal5, Kerasal, Salvax Duo, Salvax Duo Plus
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Salvax Duo Plus
- Insulin glargine and lixisenatide Subcutaneous-Salvax Topical
- Insulin glargine and lixisenatide Subcutaneous-Samarium Sm 153 Lexidronam
- Insulin glargine and lixisenatide Subcutaneous-Samarium sm 153 lexidronam Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Samsca
- Insulin glargine and lixisenatide Subcutaneous-Sanctura
- Salvax Duo-Insulin glargine, recombinant Subcutaneous
- Salvax Duo-Insulin glulisine
- Salvax Duo-Insulin Glulisine (Cartridges and Pens)
- Salvax Duo-Insulin Glulisine (Vials)
- Salvax Duo-Insulin glulisine Subcutaneous
- Salvax Duo-Insulin human inhaled Inhalation